Mostra i principali dati dell'item

dcterms.contributor.authorApóstolo, Joao
dcterms.contributor.authorBobrowicz-Campos, Elzbieta
dcterms.contributor.authorMoreno-Casbas, Teresa
dcterms.contributor.authorTeixeira-Santos, Luisa
dcterms.contributor.authorSánchez de Madariaga, Ricardo
dcterms.contributor.authorCasado-Ramírez, Elvira
dcterms.contributor.authorCouto, Filipa
dcterms.contributor.authorCoelho, Adriana Neves
dcterms.contributor.authorParola, Vitor
dcterms.contributor.authorGil, Isabel María
dcterms.contributor.authorPascual-Carrasco, Mario
dcterms.contributor.authorAlmeida, Maria de Lurdes
dcterms.contributor.authorModulEn consortium
dc.date.accessioned2020-06-16T08:25:06Z
dc.date.available2020-06-16T08:25:06Z
dcterms.date.issued2019
dcterms.identifier.citationApóstolo J, Bobrowicz-Campos E, Moreno-Casbas T, Teixeira-Santos L, Sánchez de Madariaga R, Casado-Ramírez E, Couto F, Coelho A, Parola V, Gil I, Pascual-Carrasco M, Almeida M de L, and ModulEn consortium. A study protocol for development and validation of a clinical prediction model for frailty (ModulEn): a new European commitment to tackling frailty. Translational Medicine @ UniSa 2019, 19(6): 36-41.it_IT
dcterms.identifier.issn2239-9747it_IT
dcterms.identifier.urihttp://www.translationalmedicine.unisa.it/indexit_IT
dcterms.identifier.urihttp://elea.unisa.it:8080/xmlui/handle/10556/4532
dcterms.identifier.urihttp://dx.doi.org/10.14273/unisa-2726
dc.description.abstractThere is a growing need to implement and evaluate the technological solutions that allow the early detection of age-related frailty and enable assessment of the predictive values of frailty components. The broad use of these solutions may ensure an efficient and sustainable response of health and social care systems to the challenges related to demographic aging. In this paper, we present the protocol of the ModulEn study that aims to develop and validate a predictive model for frailty. For this purpose, the sample composed by older adults aged 65-80 years and recruited from the community will be invited to use an electronic device ACM Kronowise® 2.0. This device allows proactive and continuous monitoring of circadian health, physical activity, and sleep and eating habits. It will be used during a period of seven to ten days. The participants will also be given the questionnaires evaluating the variables of interest, including frailty level, as well as their experience and satisfaction with the device use. Data provided from these two sources will be combined and the relevant associations will be identified. In our view, the implications of this study' findings for clinical practice include the possibility to develop and validate tools for timely prevention of frailty progress. In the long term, the ModulEn may contribute to the critical reduction of frailty burden in Europe.it_IT
dcterms.format.extentP. 36-41it_IT
dc.language.isoitit_IT
dcterms.sourceUniSa. Sistema Bibliotecario di Ateneoit_IT
dcterms.subjectOlder adultsit_IT
dcterms.subjectFrailtyit_IT
dcterms.subjectCircadian healthit_IT
dcterms.subjectPredictive modelit_IT
dcterms.subjectCitizen engagementit_IT
dcterms.subjectDigital solutionsit_IT
dcterms.titleA study protocol for development and validation of a clinical prediction model for frailty (ModulEn): a new European commitment to tackling frailtyit_IT
dcterms.typeArticleit_IT
 Find Full text

Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item